CAR-T Cell Therapy Market Share, Size, Trends, Industry Analysis Report By Target Antigen (CD19/CD22, BCMA, Others); By Indication (Diffuse Large B-Cell Lymphoma (DLBCL), Acute Lymphoblastic Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), Follicular Lymphoma (FL), Others); By Regions: Segment Forecast, 2020 – 2026

Table of Contents

1. Overview and Scope
   1. Research goal & scope
   2. Research assumptions
   3. Research Methodology
      1. Primary data sources
      2. Secondary data sources
   4. Key take-aways
   5. Stakeholders
2. Executive Summary
   1. Market Definition
   2. Market Segmentation
3. CAR-T Cell Therapy Market –Premium Insights
   1. CAR-T Cell Therapy– Industry snapshot
   2. CAR-T Cell Therapy- Ecosystem analysis
   3. CAR-T Cell Therapy Market dynamics
      1. CAR-T Cell Therapy– Market Forces
         1. CAR-T Cell Therapy Market driver analysis
         2. CAR-T Cell Therapy Market restraint/challenges analysis
         3. CAR-T Cell Therapy Market opportunity analysis
   4. Industry analysis - Porter's five force analysis
   5. CAR-T Cell Therapy Market PEST analysis, 2019
   6. CAR-T Cell Therapy Industry trends
   7. Competitive Ranking Analysis
   8. Timeline of CAR-T Cell Therapy Development
   9. CAR-T Cell Manufacturing Process
   10. Side-effects of CAR-T Cell
   11. Antigens targeting solid tumors
   12. 临床试验s Landscape for CAR-T
   13. Commercial Landscape (Mergers & Acquisitions, Partnerships & Collaborations)
   14. New Innovations in CAR-T therapies
4. CAR-T Cell Therapy Market Size and Forecast 2017 - 2026 by Target Antigen
   1. Key findings
   2. CD19/CD22
      1. Global CD19/CD22 market estimates & forecast, 2017 – 2026
      2. Global CD19/CD22 market estimates & forecast, by region, 2017 - 2026
   3. BCMA (B-Cell Maturation Antigen)
      1. Global BCMA market estimates & forecast, 2017 - 2026
      2. Global BCMA market estimates & forecast, by region, 2017 - 2026
   4. Others (MUC16, L1CAM, ROR1, EGFRvIII, PSCA, NKR-2, IL13Ra2, LewisY)
      1. Global Other Target Antigen market estimates & forecast, 2017 - 2026
      2. Global Other Target Antigen market estimates & forecast, by region, 2017 - 2026
5. CAR-T Cell Therapy Market Size and Forecast by Indication
   1. Key findings
   2. Diffuse Large B-Cell Lymphoma (DLBCL)
      1. Global DLBCL market estimates & forecast, 2017 - 2026
      2. Global DLBCL market estimates & forecast, by region, 2017 - 2026
   3. Acute Lymphoblastic Leukemia (ALL)
      1. Global ALL market estimates & forecast, 2017 - 2026
      2. Global ALL market estimates & forecast, by region, 2017 - 2026
   4. Chronic Lymphocytic Leukemia (CLL)
      1. Global CLL market estimates & forecast, 2017 - 2026
      2. Global CLL market estimates & forecast, by region, 2017 - 2026
   5. Multiple Myeloma (MM)
      1. Global MM market estimates & forecast, 2017 - 2026
      2. Global MM market estimates & forecast, by region, 2017 - 2026
   6. Follicular Lymphoma (FL)
      1. Global FL market estimates & forecast, 2017 - 2026
      2. Global FL market estimates & forecast, by region, 2017 - 2026
   7. Others
      1. Global Other indications market estimates & forecast, 2017 - 2026
      2. Global Other indications market estimates & forecast, by region, 2017 - 2026
6. CAR-T Cell Therapy Market Size and Forecast by Regions
   1. Key findings
   2. U.S.
      1. U.S. CAR-T Cell Therapy Market by Target Antigen, 2017-2026
      2. U.S. CAR-T Cell Therapy Market by Indication, 2017 - 2026
   3. Europe
      1. Europe CAR-T Cell Therapy Market by Target Antigen, 2017 - 2026
      2. Europe CAR-T Cell Therapy Market by Indication, 2017 - 2026
   4. Japan
      1. Japan CAR-T Cell Therapy Market by Target Antigen, 2017 - 2026
      2. Japan CAR-T Cell Therapy Market by Indication, 2017 - 2026
   5. Rest of the World
      1. RoW CAR-T Cell Therapy Market by Target Antigen, 2017 - 2026
      2. RoW CAR-T Cell Therapy Market by Indication, 2017 - 2026
7. Company Profiles
   1. Amgen Inc. (US)
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   2. Bellicum Pharmaceuticals, Inc. (US)
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   3. Bluebird Bio (US)
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   4. Caribou Biosciences, Inc. (US)
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   5. Celgene Corporation (US)(acquired by Bristol-Myers Squibb)
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   6. Cellectis (France)
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   7. Celyad (Belgium)
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   8. Gilead Sciences, Inc. (US)
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   9. Intellia Therapeutics (US)
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   10. Johnson & Johnson (US)
       1. Overview
       2. Financials
       3. Product Benchmarking
       4. Recent Developments
   11. Mereck KGaA (Germany)
       1. Overview
       2. Financials
       3. Product Benchmarking
       4. Recent Developments
   12. Nanjing Legend Biotechnology Co., Ltd. (China)
       1. Overview
       2. Financials
       3. Product Benchmarking
       4. Recent Developments
   13. Noile-Immune Biotech (Japan)
       1. Overview
       2. Financials
       3. Product Benchmarking
       4. Recent Developments
   14. Novartis International AG (Swiss)
       1. Overview
       2. Financials
       3. Product Benchmarking
       4. Recent Developments
   15. Pfizer Inc. (US)
       1. Overview
       2. Financials
       3. Product Benchmarking
       4. Recent Developments
   16. Sangamo Therapeutics, Inc. (US)
       1. Overview
       2. Financials
       3. Product Benchmarking
       4. Recent Developments
   17. Servier Laboratories (France)
       1. Overview
       2. Financials
       3. Product Benchmarking
       4. Recent Developments

List of Tables

Table 1 Global CAR-T Cell Therapy Market, 2015 - 2026, (USD Million)
Table 2 Global CAR-T Cell Therapy Market by Region, 2015 - 2026, (USD Million)
Table 3 Global CAR-T Cell Therapy Market by Target Antigen, 2015 - 2026, (USD Million)
Table 4 Global CAR-T Cell Therapy Market by Indication, 2015 - 2026, (USD Million)
Table 5 Global CD19/CD22 market estimates & forecast, 2017 – 2026, (USD Million)
Table 6 Global CD19/CD22 market estimates & forecast, by region, 2017 - 2026, (USD Million)
Table 7 Global BCMA market estimates & forecast, 2017 - 2026, (USD Million)
Table 8 Global BCMA market estimates & forecast, by region, 2017 - 2026, (USD Million)
Table 9 Global Other Target Antigen market estimates & forecast, 2017 - 2026, (USD Million)
Table 10 Global Other Target Antigen market estimates & forecast, by region, 2017 - 2026, (USD Million)
Table 11 Global DLBCL market estimates & forecast, 2017 - 2026, (USD Million)
Table 12 Global DLBCL market estimates & forecast, by region, 2017 - 2026, (USD Million)
Table 13 Global ALL market estimates & forecast, 2017 - 2026, (USD Million)
Table 14 Global ALL market estimates & forecast, by region, 2017 - 2026, (USD Million)
Table 15 Global CLL market estimates & forecast, 2017 - 2026, (USD Million)
Table 16 Global CLL market estimates & forecast, by region, 2017 - 2026, (USD Million)
Table 17 Global MM market estimates & forecast, 2017 - 2026, (USD Million)
Table 18 Global MM market estimates & forecast, by region, 2017 - 2026, (USD Million)
Table 19 Global FL market estimates & forecast, 2017 - 2026, (USD Million)
表20全球FL市场估计和预测region, 2017 - 2026, (USD Million)
Table 21 Global Other indications market estimates & forecast, 2017 - 2026, (USD Million)
Table 22 Global Other indications market estimates & forecast, by region, 2017 - 2026, (USD Million)
Table 23 U.S. CAR-T Cell Therapy Market by Target Antigen, 2017-2026, (USD Million)
Table 24 U.S. CAR-T Cell Therapy Market by Indication, 2017 - 2026, (USD Million)
Table 25 Europe CAR-T Cell Therapy Market by Target Antigen, 2017 - 2026, (USD Million)
Table 26 Europe CAR-T Cell Therapy Market by Indication, 2017 - 2026, (USD Million)
Table 27 Japan CAR-T Cell Therapy Market by Target Antigen, 2017 - 2026, (USD Million)
Table 28 Japan CAR-T Cell Therapy Market by Indication, 2017 - 2026, (USD Million)
Table 29 RoW CAR-T Cell Therapy Market by Target Antigen, 2017 - 2026, (USD Million)
Table 30 RoW CAR-T Cell Therapy Market by Indication, 2017 - 2026, (USD Million)

List of Figures

FIG. 1 Market snapshot
FIG. 2 Market segmentation
FIG. 3 CAR-T Cell Therapy — Market size and growth prospects
FIG. 4 CAR-T Cell Therapy — Value chain analysis
FIG. 5 Market dynamics
FIG. 6 Porter’s five forces analysis
FIG. 7 Penetration & growth prospect mapping
FIG. 8 Key Company Analysis, 2019
FIG. 9 CAR-T Cell Therapy — PEST analysis
FIG. 10 CAR-T Cell Therapy Market: Target Antigen Share Analysis
FIG. 11 CAR-T Cell Therapy Market: Indication Share Analysis
FIG. 12 Regional market place: Key takeaways